Abstract:Aim To study the mechanisms of caveolin-1 (Cav-1) up-regulating the extracellular Ca2+-sensing receptor (CaR)-induced endothelial nitric oxide synthetase (eNOS) activation in human umbilical vein endothelial cells (HUVECs). Methods Cultured HUVECs, the same generation of cells were randomly divided into: (1)control group (2)CaR agonist (spermine, 2.0 mmol/L)+Ca2+ group (3)caveolae structural damage (filipin, 1.5 mg/L)+spermine+Ca2+ group (4)Cav-1 short hairpin RNA (Cav-1 ShRNA)+spermine+Ca2+ group (5)vehicle+spermine+Ca2+ group (6)different concentrations (1.5, 2.0, 2.5 mg/L) filipin groups. Western blotting experiments were performed to detect protein expression of Cav-1, eNOS, phosphorated eNOS (p-eNOS) and expressions of Cav-1 and eNOS membrane proteins. The interaction and co-localization between eNOS and Cav-1 were determined using co-immunoprec-ipitates and immunofluorescence analysis, respectively. Results Different concentrations filipin did not influence the expression of eNOS and p-eNOS protein in HUVECs. In the presence of Ca2+, the CaR agonist spermine at concentration of 2.0 mmol/L resulted in an increase in the p-eNOS in HUVECs (P<0.05), the effect of spermine on the increase of p-eNOS was also completely blocked after acute caveolae disruption with filipin (1.5 mg/L) or transfected with Cav-1 ShRNA (P<0.05). The expression of the eNOS membrane protein was decreased in HUVECs after cells were treated by filipin (1.5 mg/L) or transfected with Cav-1 ShRNA. Simultaneously, total protein level of eNOS was unaffected. Immunocytochemical results demonstrated that filipin (1.5 mg/L) or transfected with Cav-1 ShRNA decreased eNOS localization in caveolae, increased in the local area surrounding the nucleus. Compared with control group and spermine+Ca2+ group, the interaction of eNOS and Cav-1 in Cav-1 ShRNA group was attenuated (P<0.05). Conclusions Cav-1 might promote CaR-induced eNOS activation. The mechanisms are involved in the effect of Cav-1 on eNOS localization at the plasma membrane and the inhibition of eNOS translocation to the organelles.